Nexplanon is a contraceptive implant and a newer type of Implanon. In a recent study, Nexplanon was shown to be associated with a 40% increase in the risk of blood clots. If you or someone you know has suffered from Nexplanon side effects or blood clots, you are not the only one. Alabama Nexplanon attorneys can help you receive the financial compensation that you deserve.
Nexplanon is a contraceptive implant that is inserted under the skin of the upper arm. The device is the size of a match stick and slowly releases a synthetic version of the hormone that is named progestin. Less than one percent of woman who have Nexplanon implant will get pregnant because the hormones increase the density of cervical mucous, which eliminates the probability that a sperm will enter the uterus. In addition, the drug is an ovulatory inhibitor, so there is little chance that eggs will be present for fertilization. With Alabama Nexplanon attorneys, a person can receive professional representation that works to ensure medical bills are covered.
Alabama Nexplanon Attorneys Warn of Side Effects
Both Implanon and Nexplanon have the same dose of hormones, similar risks and side effects. The major difference between the two products is theta Nexplanon is easily located on a CT scan or X-ray. Nexplanon also features a pre-loaded applicator, so it is easier to implant and has reduced risks of surgical errors. A recent study in Denmark four that patients who rely on hormonal contraceptives that are not take orally have a higher risk of blood clots. The study was released in the British Medical Journal, and researchers pointed to an increased risk of nearly 40%.
In the study, researchers looked at the chances for blood clots in Danish women who were between 15 and 48. The decade-long study included women who were not currently pregnant and had no genetic history of cancer or blood clots. The study found that only one non-oral contraceptive did not correlate with an increased probability of blood clots. Any implants that were subcutaneously inserted had a 40 percent higher risk. The researchers analyzed the risk of blood clots and other thrombolic events in Danish women between the ages of 15-49, from 2001 to 2010. The women were not pregnant and had no history of blood clots or cancer.
Risk of Blood Clots from Taking Nexplanon
Blood clots are a serious emergency and can lead to serious consequences. Usually, the human body uses blood’s clotting action to prevent excessive blood loss. The main problem with spontaneous blood clots is that they have a tendency to restrict arterial flow and can lead to cell death. Most clots form in the lower legs, and the condition is termed deep vein thrombosis. If the clots are given time to grow, they can become exponentially large and lead to permanent blood vessel damage.
Because blood clots can also travel through the veins and arteries, it may become trapped in a major organ. In the lower body, blood clots are usually pumped to the lungs and can lead to a pulmonary embolism. On the other hand, a blood clot that forms in the arteries may be pumped to the brain or hear and cause a stroke, heart attack or lead to death.
Nexplanon’s most serious side effects are the blood clots that are associated with the drug. Because the clots can often form undetected, they can quickly lead to disability or death. Every woman who has received a Nexplanon implant has an increased risk of blood clots and other side effects. Women who smoke or have other risk factors have the highest chance of serious side effects.
Alabama Nexplanon attorneys warn of the following side effects:
- Change in menstrual bleeding; irregular, unpredictable bleeding.
- Abdominal pain.
- Weight gain.
- Blood clots.
- Vaginal infections.
Get In Touch With Alabama Nexplanon Attorneys
If you’re looking for Alabama Nexplanon attorneys, Attorney Group for Alabama can help hold the manufacturer of Nexplanon accountable for their product, like we’ve done with other dangerous drug cases. Contact us today to discuss your eligibility for representation in a free case review.